|
|
| U0126 / Promega (0 Trials) |
|
| U16 / Shanghai Unicar (0 Trials) |
|
| U3-1565 / Daiichi Sankyo (0 Trials) |
|
| U3-1784 / Daiichi Sankyo (0 Trials) |
|
| U51 / Shanghai Unicar (0 Trials) |
|
| U87 / Shanghai Unicar (0 Trials) |
|
| UAB30 / UAB University - Birmingham (0 Trials) |
|
| UB 312 / Vaxxinity (0 Trials) |
|
| UB-221 / United BioPharma (0 Trials) |
|
| UB-311 / Vaxxinity (0 Trials) |
|
| UB-313 / Vaxxinity (0 Trials) |
|
| UB-421 IV / United BioPharma (0 Trials) |
|
| UB-421 SC / United BioPharma (0 Trials) |
|
| UB-551 / UBI Pharma (0 Trials) |
|
| UB-612 / Vaxxinity (0 Trials) |
|
| UB-621 / United BioPharma (0 Trials) |
|
| UB-921 (trastuzumab biosimilar) / United BioPharma (0 Trials) |
|
| UB-923 (rituximab biosimilar) / United BioPharma (0 Trials) |
|
| UB-iC200 / Umoja Biopharma (0 Trials) |
|
| UB-RN200 / Umoja Biopharma (0 Trials) |
|
| UB-VV100 / Umoja Biopharma (0 Trials) |
|
| UB-VV200 / Umoja Biopharma (0 Trials) |
|
| ubamatamab (REGN4018) / Regeneron (0 Trials) |
|
| UBB2048 / Unity Biotech (0 Trials) |
|
| ubenimex (DFP-14323) / Delta-Fly Pharma (0 Trials) |
|
| UBG-T/NK/γδ T-cell therapy / Guangzhou Bio-gene Technology (0 Trials) |
|
| UBG-T19 / Hedy Group (0 Trials) |
|
| UBI-VLP-201 / UbiVac (0 Trials) |
|
| ubidecarenone IV (BPM31510 IV) / BPGbio (2 Trials) |
|
| ubidecarenone topical (BPM 31510) / BPGbio (1 Trials) |
|
| UbiQGel (co-enzyme Q10) / Tishcon (1 Trials) |
|
| ubiquitin-competing molecule / Fratagene (0 Trials) |
|
| ubiquitin-protein ligase inhibitor / Progenra (0 Trials) |
|
| UBP-HER2-CART / UWELL Biopharma (0 Trials) |
|
| UBP1213 / Shanghai Junshi Biosci (0 Trials) |
|
| Ubrelvy (ubrogepant) / AbbVie (8 Trials) |
|
| UBX-106 / Ubix Therap, SK Bio (0 Trials) |
|
| UBX-1967 / Ascentage Pharma (0 Trials) |
|
| UBX-303-1 / Ubix Therap (0 Trials) |
|
| UBX-306 / Ubix Therap, NeoImmuneTech (0 Trials) |
|
| UBX-382 / Ubix Therap (0 Trials) |
|
| UBX0101 / Unity Biotech (0 Trials) |
|
| UBX2050 / Unity Biotech (0 Trials) |
|
| UC-MSCs / Zhongyuan Union Cell & Gene (0 Trials) |
|
| UC101 / Chengdu USino Techno (0 Trials) |
|
| UCART / Beijing Imunopharm (0 Trials) |
|
| UCART CS1 / Cellectis (1 Trials) |
|
| UCART for Solid Tumors / EdiGene (0 Trials) |
|
| UCART-19 / Shenzhen Feipeng Biological Therap (0 Trials) |
|
| UCART-5T4 / Cellectis (0 Trials) |
|
| UCART-EGFRVIII / Cellectis (0 Trials) |
|
| UCART123 / Cellectis (1 Trials) |
|
| UCART19 / Allogene Therap, Servier (1 Trials) |
|
| UCART33 / Cellectis (0 Trials) |
|
| UCART38 / Cellectis, Pfizer (0 Trials) |
|
| UCARTCLL1 / Cellectis (0 Trials) |
|
| UCARTFAP / Cellectis (0 Trials) |
|
| UCARTMESO / Cellectis (0 Trials) |
|
| UCARTMUC1 / Cellectis (0 Trials) |
|
| UCB-HPDSC / BMS (0 Trials) |
|
| UCB7853 / UCB, Novartis (0 Trials) |
|
| UCB8600 / UCB (0 Trials) |
|
| UCD19 CAR T Cells / University of Colorado (0 Trials) |
|
| ucenprubart (LY3454738) / Eli Lilly (0 Trials) |
|
| UCL70802 / UTC Therap (0 Trials) |
|
| UCLM802 / UTC Therap (0 Trials) |
|
| UCPVax / Invectys (0 Trials) |
|
| UCT-01-097 / 1200 Pharma (0 Trials) |
|
| UCT-03-008 / 1200 Pharma (0 Trials) |
|
| UCT943 / University of Cape Town, Medicines for Malaria Venture (0 Trials) |
|
| UD TGFbetai NK cells / The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Instit (0 Trials) |
|
| Udenyca (pegfilgrastim-cbqv) / Intas (1 Trials) |
|
| udonitrectag (REC 0559) / Recordati, MimeTech (0 Trials) |
|
| UF-KURE19 / Case Comprehensive Cancer Center, Kure.ai (0 Trials) |
|
| UGN-501 / UroGen (0 Trials) |
|
| UGP281 / Enteris (0 Trials) |
|
| UHE-103 / Therapeutics Inc (0 Trials) |
|
| UI-201 / United Immunity (0 Trials) |
|
| UISH001 / Beech Tree Labs (0 Trials) |
|
| Ujvira (trastuzumab emtansine biosimilar) / Zydus Lifesci (0 Trials) |
|
| UK 432097 / Pfizer (0 Trials) |
|
| UK-383367 / Pfizer (0 Trials) |
|
| UK-421045 / Pfizer (0 Trials) |
|
| Ukoniq (umbralisib) / TG Therap (4 Trials) |
|
| Ukrain (NSC B238865) / Nowicky (0 Trials) |
|
| ulefnersen (ION363) / Ionis, Otsuka (0 Trials) |
|
| ulenistamab (PBP1510) / Prestige BioPharma (1 Trials) |
|
| Ulesfia (benzyl alcohol) / Advanz Pharma (0 Trials) |
|
| ulevostinag (MK-1454) / Merck (MSD) (2 Trials) |
|
| uliledlimab (TJD5) / NovaBridge Biosciences, Tracon Pharma (0 Trials) |
|
| ulinastatin injection / Generic mfg. (0 Trials) |
|
| ulixacaltamide (PRAX-944) / Praxis Precision Medicines (0 Trials) |
|
| ulixertinib (BVD-523) / BioMed Valley Discoveries (10 Trials) |
|
| ulobetasol propionate lotion / Therapeutics Inc (0 Trials) |
|
| ulocuplumab (BMS-936564) / BMS (1 Trials) |
|
| ulodesine (BCX4208) / BioCryst (0 Trials) |
|
| ulodesine (LR 09) / Laevoroc Oncology (0 Trials) |
|
| ulonivirine (MK-8507) / Merck (MSD) (0 Trials) |
|
| ulotaront (SEP-363856) / Otsuka (2 Trials) |
|
| Ultibro (glycopyrronium/indacaterol) / Novartis (3 Trials) |
|
| Ultomiris (ravulizumab-cwvz) / AstraZeneca (33 Trials) |
|
| Ultomiris SC QW (ravulizumab-cwvz SC) / AstraZeneca (0 Trials) |
|
| ultra-high concentration nitric oxide (UNO101) / Beyond Air (0 Trials) |
|
| ultra-rapid acting insulin (AT247) / Arecor (0 Trials) |
|
| ultra-rapid-acting recombinant human insulin (BIOD-123) / Ipsen (0 Trials) |
|
| Ultracillin (ampicillin / sulbactum) / SEDICO (0 Trials) |
|
| Ultravate (halobetasol proprionate) / Sun Pharma (0 Trials) |
|
| ulviprubart (ABC008) / Abcuro (0 Trials) |
|
| UM-164 / University of Michigan (0 Trials) |
|
| umbilical cord blood cells (ALD-601) / Nuo Therapeutics (0 Trials) |
|
| umbilical cord blood derived natural killer cells / Huzhou Science And Technology Bureau (0 Trials) |
|
| umbilical cord blood mononuclear cells / Xiangyang 1st people's Hospital (0 Trials) |
|
| umbilical cord blood-mediated CAR-T / Beijing Menlo Biotech (0 Trials) |
|
| umbilical cord derived mesenchymal cells / Child Jesus University Children's Hospital (0 Trials) |
|
| umbilical cord derived mesenchymal stem cell therapy (UC-MSC) / Tuohua Biological Technology (0 Trials) |
|
| umbilical cord derived mesenchymal stem cell therapy (UC-MSC) / Jiangxi Mayo Biotech (0 Trials) |
|
| umbilical cord generated dendritic cell immunotherapy (BRS-001) / Therapeutic Solutions (0 Trials) |
|
| umbilical cord mesenchymal stem cell therapy / Predictive Technology Group (0 Trials) |
|
| umbilical cord mesenchymal stem cell therapy / RE-Stem (0 Trials) |
|
| umbilical cord mesenchymal stem cell therapy (hUC-MSC) / Shenzhen Beike Biotech (0 Trials) |
|
| umbilical cord mesenchymal stem cells / Hunan Yuanpin Cell Biotech (0 Trials) |
|
| umbilical cord mesenchymal stem cells / Jackson Health System, University of Miami, The Cure Alliance (0 Trials) |
|
| umbilical cord mesenchymal stem cells / Hebei Newtherapy BIo-Pharma Technology (0 Trials) |
|
| umbilical cord mesenchymal stem cells / Fuzhou General Hospital (0 Trials) |
|
| umbilical cord mesenchymal stem cells / Vinmec (0 Trials) |
|
| umbilical cord Wharton's jelly-derived human MSC / Public Assistance - Paris Hospitals (0 Trials) |
|
| UMC01 / Ever Supreme Bio Tech (0 Trials) |
|
| UMC119-01 / Xuanjie (0 Trials) |
|
| UMC119-06-05 / Xuanjie (0 Trials) |
|
| umedaptanib pegol (RBM-007) / RIBOMIC (0 Trials) |
|
| UMG2-CD3 BTCE / Magna Graecia University (0 Trials) |
|
| umibecestat (CNP520) / Novartis, Amgen, Banner Alzheimer’s Institute (0 Trials) |
|
| umikibart (YYB-101) / National OncoVenture, CellabMed (0 Trials) |
|
| umitrelimorgene autodencel (ITI-1000) / Immunomic Therapeutics (0 Trials) |
|
| UN04 / Korea United Pharm (0 Trials) |
|
| unadjuvanted RSV maternal vaccine (GSK3888550A) / GSK (0 Trials) |
|
| Unafra (opiranserin) / Vivozon (0 Trials) |
|
| unasnemab (MT-3921) / Mitsubishi Tanabe, Osaka University (0 Trials) |
|
| UNC1999 / University of North Carolina-Chapel Hill (0 Trials) |
|
| UNC2025 / University of North Carolina-Chapel Hill (0 Trials) |
|
| Undisclosed 5T4 x CD137 based bispecific antibody / Crescendo Biologics (0 Trials) |
|
| Undisclosed 5T4 X CD3 antibody / Amgen (0 Trials) |
|
| Undisclosed A-Kine therapeutic / Orionis (0 Trials) |
|
| Undisclosed a-syn degrader / APRINOIA Therap (0 Trials) |
|
| Undisclosed A2AR based DFC / Merck (MSD) (0 Trials) |
|
| Undisclosed A2AR/CD73 small molecule inhibitor / Evotec, Recursion Pharma (0 Trials) |
|
| Undisclosed ACTallo program / Immatics, BMS (0 Trials) |
|
| Undisclosed ACTallo program 1 / Immatics, BMS (0 Trials) |
|
| Undisclosed AD therapeutic / Issar (0 Trials) |
|
| Undisclosed ADAM10-targeted CAR-T cell therapy / Carina Biotech (0 Trials) |
|
| Undisclosed ADC targeting Nectin family members / Nectin Therap (0 Trials) |
|
| Undisclosed ADC therapeutic / J&J, Servier (0 Trials) |
|
| Undisclosed ADC therapeutic / GeneQuantum Healthcare, Aimed Bio (0 Trials) |
|
| Undisclosed ADC therapeutic / Eli Lilly, Lonza (0 Trials) |
|
| Undisclosed Affimer AKT inhibitor TMAC / Avacta (0 Trials) |
|
| Undisclosed Affimer CDK inhibitor TMAC / Avacta (0 Trials) |
|
| Undisclosed Affimer Proteasome inhibitor TMAC / Avacta (0 Trials) |
|
| Undisclosed Affimer STING agonist TMAC / Avacta (0 Trials) |
|
| Undisclosed Affimer TLR7/8 agonist TMAC / Avacta (0 Trials) |
|
| Undisclosed aKRAS G12V / Oblique Therap (0 Trials) |
|
| Undisclosed aKRAS G13D / Oblique Therap (0 Trials) |
|
| Undisclosed ALK inhibitor / Sareum (0 Trials) |
|
| Undisclosed ALK inhibitor / Nuvalent (0 Trials) |
|
| Undisclosed ALK-1/VEGF bispecific antibody / Kintor Pharma (0 Trials) |
|
| Undisclosed ALK5 inhibitor / Carna Biosci (0 Trials) |
|
| Undisclosed allogeneic personalized cell therapy / Adaptimmune, Roche (0 Trials) |
|
| Undisclosed allogeneic TAC-γδ cell therapy / Triumvira (0 Trials) |
|
| Undisclosed alopecia therapeutic / MPC Therap (0 Trials) |
|
| Undisclosed alpha synuclein inhibitor / Arvinas (0 Trials) |
|
| Undisclosed ALS ASO / Trace Neuroscience (0 Trials) |
|
| Undisclosed ALS small molecule therapeutic / Maze Therap (0 Trials) |
|
| Undisclosed ALS therapeutic / Aquinnah Pharma, Roche (0 Trials) |
|
| Undisclosed ALS therapeutic / ImmunoBrain Checkpoint (0 Trials) |
|
| Undisclosed ALS therapeutic / Eli Lilly, Verge Genomics (0 Trials) |
|
| Undisclosed ALS therapy / Treeway, Leiden University Medical Center (0 Trials) |
|
| Undisclosed ALS therapy / Neuron23 (0 Trials) |
|
| Undisclosed ALS/FTLD therapeutic / Merck (MSD), TuHURA Bio (0 Trials) |
|
| Undisclosed Alzheimer's therapeutic / Prothena (0 Trials) |
|
| Undisclosed Alzheimer's therapeutic / Alectos (0 Trials) |
|
| Undisclosed Alzheimer's therapeutic / Mabylon (0 Trials) |
|
| Undisclosed Alzheimer's therapeutic / Shanghai SIMR Biotech (0 Trials) |
|
| Undisclosed Alzheimer's therapeutic / MPC Therap (0 Trials) |
|
| Undisclosed anti CLDN 18.2 Antibody / CS Group (0 Trials) |
|
| Undisclosed anti HER2/PD-L1 bispecific antibody / Fontacea (0 Trials) |
|
| Undisclosed anti LAG3/PD-1 BsAb / Fontacea (0 Trials) |
|
| Undisclosed anti MUC1 C2-BsAbs / Minerva Biotech (0 Trials) |
|
| Undisclosed anti PD-1 mAb / Cellectis, MabQuest (0 Trials) |
|
| Undisclosed anti SIRPα/PD-L1 bispecific antibody / Fontacea (0 Trials) |
|
| Undisclosed anti TDP-43 antibody / AC Immune (0 Trials) |
|
| Undisclosed anti-c-MET/PD-L1 antibody / Sorrento (0 Trials) |
|
| Undisclosed anti-CD52 monoclonal antibody / Sinopharm (0 Trials) |
|
| Undisclosed anti-CLDN18.2/anti-CD3 bispecific antibody / Accurus Biosci (0 Trials) |
|
| Undisclosed anti-CTLA4 antibody / Premier Biomedical (0 Trials) |
|
| Undisclosed anti-CTLA4 antibody / Abzena (0 Trials) |
|
| Undisclosed anti-FOXP3 ASO / AUM LifeTech (0 Trials) |
|
| Undisclosed anti-L1CAM ADC / CIS Pharma (0 Trials) |
|
| Undisclosed anti-LAG3 mAb / Protheragen (0 Trials) |
|
| Undisclosed anti-MICA/B antibody / BMS (0 Trials) |
|
| Undisclosed anti-MSLN/CD3 BiTE / Amgen (0 Trials) |
|
| Undisclosed anti-MUC1-Ab / Protheragen (0 Trials) |
|
|